Kobayakawa H, Miyata T, Inagi R, Shinzato T, Maeda K
Department of Internal Medicine, Nagoya University School of Medicine, Japan.
Nihon Jinzo Gakkai Shi. 1992 Jan;34(1):103-6.
The present study was undertaken to examine the effects of excess factor D build-up in the body of end-stage renal disease (ESRD) patients upon the activation of the alternative pathway and the terminal pathway in the fluid phase. First, to clarify the effect of excess factor D on the alternative pathway, purified factor D from an ESRD patient was added to normal serum and the changes in concentrations of C3a-des-Arg and C5a-des-Arg were investigated. The results showed that once the serum factor D level reached a concentration corresponding to 15 micrograms/ml in the serum of the ESRD patient, the C3a-des-Arg and C5a-des-Arg levels had climbed to about 1.7-fold the concentration in normal serum. Next, in order to clarify the effect of excess factor D on the terminal pathway, purified factor D was added to normal serum, and the changes in C5b6 generation were examined. The results indicated that as the factor D level increased in the serum, the C5b6 level rose gradually also; and when the factor D concentration reached 15 micrograms/ml, the C5b6 generation had risen to approximately 1.5-fold the level in normal serum. The present results therefore suggest that factor D build-up in ESRD patients provides a uremic toxin that can cause abnormal activation of the whole complement cascade.
本研究旨在探讨终末期肾病(ESRD)患者体内过量的因子D积累对液相中替代途径和终末途径激活的影响。首先,为了阐明过量因子D对替代途径的影响,将来自ESRD患者的纯化因子D添加到正常血清中,并研究C3a-去精氨酸和C5a-去精氨酸浓度的变化。结果表明,一旦血清因子D水平达到ESRD患者血清中相当于15微克/毫升的浓度,C3a-去精氨酸和C5a-去精氨酸水平就会攀升至正常血清浓度的约1.7倍。接下来,为了阐明过量因子D对终末途径的影响,将纯化因子D添加到正常血清中,并检测C5b6生成的变化。结果表明,随着血清中因子D水平的升高,C5b6水平也逐渐升高;当因子D浓度达到15微克/毫升时,C5b6生成已升至正常血清水平的约1.5倍。因此,目前的结果表明,ESRD患者体内因子D的积累产生了一种尿毒症毒素,可导致整个补体级联反应的异常激活。